Navigation Links
Reaction to the President's State of the Union Message from Michael J. Sullivan, Pharmaceutical Industry Labor-Management Association Chair
Date:1/25/2011

WASHINGTON, Jan. 25, 2011 /PRNewswire-USNewswire/ -- The following is a statement by Michael J. Sullivan, Pharmaceutical Industry Labor-Management Association Chair:

"As we saw tonight, the momentum exists to advance a national  innovation agenda, one that stands to benefit millions of union members. But now comes the hard part: what can the administration and  Members of Congress specifically do to translate this into new jobs and a higher quality of life for working Americans? The President did a great job of selling the need for a greater focus on innovation and  competitiveness, but to do so we must identify which specific sectors and policy areas stand to have the greatest short and long-term impact here at home. In other words, where do America's working families have the most to gain? How can we continue to bring business and labor  together?

"We believe the answer lies in a strong medical innovation agenda that  takes advantage of our greatest resource: the American worker."

Michael J. Sullivan is General President of the Sheet Metal Workers International Association, AFL-CIO, and serves as Chair of the Pharmaceutical Industry Labor-Management Association.


'/>"/>
SOURCE Pharmaceutical Industry Labor-Management Association
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Free Prescription Coupons from FirstRxSavings.com Help Doctors to Evaluate Patients Reactions to Medications
2. Circassia Achieves Major Reduction in Allergic Reactions to House Dust Mite in Phase II Clinical Study of Novel T-cell Vaccine
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
5. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
6. Gene Fusion Subtypes in Prostate Carcinoma Have Clinical Implications
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
9. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
10. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
11. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of ... Farma Brasil as the company,s second affiliate in Latin America . ... ... Manager of Astellas Farma Colombia ... ...
Breaking Medicine Technology:
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):